VIENNA, April 19. /TASS/. The International Biathlon Union (IBU) forwarded the case of Russian biathlete Eduard Latypov, suspected of taking banned performance enhancing drug meldonium, to the anti-doping commission of the union, asking to clear the Russian athlete of doping charges, IBU’s press service reported on Tuesday.
"The IBU handed over the case of Mr. Latypov to the ADHP [Anti-Doping Hearing Panel] and requested to lift provisional suspension," the IBU’s press service said in a statement.
According to the statement, the request followed recent recommendations issued by the World Anti-Doping Agency regarding meldonium.
WADA announced on April 13 that the concentration of less than one microgram of meldonium in the body system of an athlete, whose doping tests were conducted before March 1, was acceptable.
The doping sample of 22-year-old Latypov was collected on February 14 in Osrblie, Slovakia, where he raced to his first international career victory after winning the sprint race at the IBU Cup. His in-competition Sample A tested positive for meldonium.
The drug meldonium (mildronate) was included in the list of preparations banned by the World Anti-Doping Agency from January 1, 2016. The presence of the meldonium substance in the athlete’s blood during and between competitions is a violation of anti-doping rules. The substance belongs to S4 class on the WADA blacklist (hormones and metabolic modulators).
Meldronate is a cardiovascular preparation freely available for purchase at pharmacies across Russia without doctor’s prescription.